Regulatory B cells: an exciting target for future therapeutics in transplantation

Transplantation is the preferred treatment for most end-stage solid organ diseases. Despite potent immunosuppressive agents, chronic rejection remains a real problem in transplantation. For many years, the predominant immunological focus of research into transplant rejection has been T cells. The pi...

Full description

Bibliographic Details
Main Authors: Alexandre eNouël, Quentin eSimon, Christophe eJamin, Jacques-Olivier ePers, Sophie eHillion
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00011/full